MN
Mohammed Naveed Yosuf
About Mohammed Naveed Yosuf
Data last updated:
Mohammed Naveed Yosuf is a Designated Partner at Calyeon Research Llp (since 2026) and Director at Ryptus Pharmaceuticals Private Limited (since 2023). The companies operate in Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Calyeon Research Llp ADC-5752 | Designated Partner | 23 Sep 2026 | 2026 | Active | |
| Ryptus Pharmaceuticals Private Limited U73100TG2022PTC166202 | Director | 16 Oct 2023 | 2022 | Active |
Board colleagues of Mohammed Naveed Yosuf
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kanda Phani Kumar | 11963230 | Calyeon Research Llp | Designated Partner |
| Raveendra Reddy Yalaya | 11963229 | Calyeon Research Llp | Designated Partner |
| Bhaskara Rao Peddi | 09120578 | Ryptus Pharmaceuticals Private Limited | Director |
| Raghuveer Peddi | 08328811 | Ryptus Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mohammed Naveed Yosuf
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mohammed Naveed Yosuf
Mohammed Naveed Yosuf currently holds 2 directorships: Calyeon Research Llp (Designated Partner, since 23 Sep 2026); Ryptus Pharmaceuticals Private Limited (Director, since 16 Oct 2023).
Mohammed Naveed Yosuf was first appointed on 16 Oct 2023 as Director at Ryptus Pharmaceuticals Private Limited. The most recent appointment on record is 23 Sep 2026 at Calyeon Research Llp.
The current boards of Mohammed Naveed Yosuf's companies include Kanda Phani Kumar (Calyeon Research Llp), Raveendra Reddy Yalaya (Calyeon Research Llp), Bhaskara Rao Peddi (Ryptus Pharmaceuticals Private Limited), Raghuveer Peddi (Ryptus Pharmaceuticals Private Limited).